These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9195070)

  • 1. Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study.
    Carmeli Y; Samore MH
    Clin Infect Dis; 1997 Jun; 24(6):1131-4. PubMed ID: 9195070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
    Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
    Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.
    Norrby SR; Finch RG; Glauser M
    J Antimicrob Chemother; 1993 Jun; 31(6):927-37. PubMed ID: 8360130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens.
    VanCouwenberghe CJ; Farver TB; Cohen SH
    Infect Control Hosp Epidemiol; 1997 May; 18(5):316-21. PubMed ID: 9154473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
    Vazquez JA; González Patzán LD; Stricklin D; Duttaroy DD; Kreidly Z; Lipka J; Sable C
    Curr Med Res Opin; 2012 Dec; 28(12):1921-31. PubMed ID: 23145859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors.
    Elting LS; Khardori N; Bodey GP; Fainstein V
    Infect Control Hosp Epidemiol; 1990 Mar; 11(3):134-8. PubMed ID: 2313082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
    Freifeld AG; Walsh T; Marshall D; Gress J; Steinberg SM; Hathorn J; Rubin M; Jarosinski P; Gill V; Young RC
    J Clin Oncol; 1995 Jan; 13(1):165-76. PubMed ID: 7799016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation on the antibiotic resistance and risky factors of nosocomial infections caused by Stenotrophomonas maltophilia].
    Zhuo C; Qian YS; Xiao GX
    Zhonghua Shao Shang Za Zhi; 2004 Feb; 20(1):10-3. PubMed ID: 15059439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated.
    Vartivarian SE; Papadakis KA; Anaissie EJ
    Arch Intern Med; 1996 Feb; 156(4):433-5. PubMed ID: 8607729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of imipenem and ceftazidime as therapy for severe melioidosis.
    Simpson AJ; Suputtamongkol Y; Smith MD; Angus BJ; Rajanuwong A; Wuthiekanun V; Howe PA; Walsh AL; Chaowagul W; White NJ
    Clin Infect Dis; 1999 Aug; 29(2):381-7. PubMed ID: 10476746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
    Wang H; Chen MJ;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stenotrophomonas (Xanthomonas) maltophilia infection in necrotizing pancreatitis.
    Mönkemüller KE; Morgan DE; Baron TH
    Int J Pancreatol; 1999 Feb; 25(1):59-63. PubMed ID: 10211423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for recovery of imipenem- or ceftazidime-resistant pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil.
    Fortaleza CM; Freire MP; Filho Dde C; de Carvalho Ramos M
    Infect Control Hosp Epidemiol; 2006 Sep; 27(9):901-6. PubMed ID: 16941313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.
    Joo EJ; Kang CI; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Lee NY; Song JH
    Microb Drug Resist; 2011 Jun; 17(2):305-12. PubMed ID: 21381966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen.
    Sanyal SC; Mokaddas EM
    J Chemother; 1999 Feb; 11(1):28-33. PubMed ID: 10078777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.
    Calza L; Manfredi R; Chiodo F
    Infection; 2003 Jun; 31(3):155-61. PubMed ID: 12789473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new selective differential medium for isolation of Stenotrophomonas maltophilia.
    Kerr KG; Denton M; Todd N; Corps CM; Kumari P; Hawkey PM
    Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):607-10. PubMed ID: 8874082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: A study of 143 patients.
    Gopalakrishnan R; Hawley HB; Czachor JS; Markert RJ; Bernstein JM
    Heart Lung; 1999; 28(2):134-41. PubMed ID: 10076113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between antibiotic usage and subsequent colonization or infection of extensive drug-resistant Acinetobacter baumannii: a matched case-control study in intensive care units.
    Tsai HT; Wang JT; Chen CJ; Chang SC
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):298-305. PubMed ID: 18707839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical manifestations of Stenotrophomas (Xanthomonas) maltophilia infection].
    Julve R; Rovira E; Belda A; Prat J; Escoms R; Albert A; Gonzalvo F
    An Med Interna; 1998 Sep; 15(9):476-80. PubMed ID: 10079538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.